Epiphany Dermatology Revenue and Competitors

Austin, TX USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Epiphany Dermatology's estimated annual revenue is currently $103.3M per year.(i)
  • Epiphany Dermatology's estimated revenue per employee is $337,500

Employee Data

  • Epiphany Dermatology has 306 Employees.(i)
  • Epiphany Dermatology grew their employee count by 22% last year.

Epiphany Dermatology's People

NameTitleEmail/Phone
1
Division VPReveal Email/Phone
2
SVP OperationsReveal Email/Phone
3
VP Finance and AccountingReveal Email/Phone
4
Senior Director Financial Planning and AnalysisReveal Email/Phone
5
Director Real EstateReveal Email/Phone
6
Chief Development OfficerReveal Email/Phone
7
Sr. Director MarketingReveal Email/Phone
8
Chief Financial OfficerReveal Email/Phone
9
Physician Recruiting DirectorReveal Email/Phone
10
Chief Medical OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15.8M65-21%N/AN/A
#2
$7.8M360%N/AN/A
#3
$2.9M18-49%N/AN/A
#4
$48.7M1645%N/AN/A
#5
$27M1002%N/AN/A
#6
$73.4M2471%N/AN/A
#7
$13.9M59-8%$9.7MN/A
#8
$63.3M2135%N/AN/A
#9
$7.6M35-3%N/AN/A
#10
$1.8M11-8%N/AN/A
Add Company

What Is Epiphany Dermatology?

We believe everyone should have prompt access to the best skin care, regardless of where they choose to live and raise their family. We believe it is our responsibility to help all patients, regardless of financial status, insurance type, or scheduling needs. In order to serve that mission, and do so in a values-based manner, we strive to work with the top professionals in their field. We believe in living out our core values of determination, excellence, common sense, teamwork, integrity, and - naturally - fun! Our physicians are exceptionally well-schooled at some of the finest medical and dermatology training programs in the country, including Harvard, Stanford, Mayo Clinic, University of Texas, University of Washington, and Washington University. We hold our corporate management team to the same high standards, so that we may provide the best support to our providers and clinical team. Exceptionally qualified and like-minded candidates are encouraged to learn more through our website listed below.

keywords:N/A

N/A

Total Funding

306

Number of Employees

$103.3M

Revenue (est)

22%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Epiphany Dermatology News

2022-03-30 - Central Colorado Dermatology Joins Epiphany Dermatology ...

Epiphany Dermatology, a leading dermatology company committed to improving access to exceptional dermatologic care, announced today it has...

2022-03-22 - Sustained Jawline Definition From Hyaluronic Gel, Study ...

Dermatologists blinded to treatment compared photos at 6 months ... Tsao has reported financial relationships with Epiphany Dermatology,...

2021-10-18 - Mid-Cities Dermatology Joins Epiphany Dermatology

AUSTIN, Texas, Oct. 18, 2021 /PRNewswire/ -- Epiphany Dermatology, a leading dermatology company committed to improving access to exceptional dermatologic care, announced today it has expanded its presence in the Dallas-Fort Worth, Texas market through its partnership with Mid-Cities Dermatology ...

2021-08-23 - Summit Dermatology Joins Epiphany Dermatology

AUSTIN, Texas, Aug. 23, 2021 /PRNewswire/ -- Epiphany Dermatology, a leading dermatology company committed to improving access to exceptional dermatologic care, announced today it has expanded its presence in the East Texas market through its partnership with Summit Dermatology. Jason Blaser, M ...

2020-12-07 - Mesquite | DeSoto Dermatology Joins Epiphany Dermatology

AUSTIN, Texas, Dec. 7, 2020 /PRNewswire/ -- Epiphany Dermatology, a leading dermatology company committed to improving access to exceptional dermatologic care, announced today it has expanded its presence in the Dallas-Fort Worth metroplex through its partnership with Mesquite | DeSoto Dermato ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$58M3060%$6.3M
#2
$62.2M3060%$20.5M
#3
$103.3M30646%N/A
#4
$103.6M30720%N/A
#5
$106.9M311N/AN/A